单词brca1
网络: 乳腺癌1号基因；乳癌基因一号；乳腺癌易感基因一型
Now an international group of researchers has found at least one reason why. BRCA1 inactivates a tumor suppressor gene known as PTEN.
现今一支国际研究小组发现原因之一是BRCA1会抑制另一种名为PTEN的基因，而PTEN基因是人体内抑制肿瘤的基因。
BRCA1 mutations in the general Ontario population were associated with higher risk of ovarian, female breast, and testicular cancers.
安大略省普通人群BRCA1突变与卵巢癌、女性乳癌、睾丸癌的高风险相关。
The researchers found that inactivating the PTEN gene in mice led to the formation of the malignant tumor associated with BRCA1 mutations.
研究人员发现，灭活小鼠的PTEN基因能诱发与BRCA1突变相关的恶性肿瘤的形成。
The rogue genes, known as BRCA 1, BRCA 2 and P53, can be identified through a blood test.
有三种通常被称为BRCA1，BRCA2和P53的劣势基因可以通过血检进行识别。
But the impact on the risk of breast cancer in post-menopausal women with a BRCA1 gene mutation was unclear, Narod"s team said.
但在绝经的BRCA1基因突变女性当中，HRT对乳腺癌患病风险会有何种影响，此前并不是很清除，Narod的团队表示。
In their normal form, BRCA1 and BRCA2 genes prevent breast cancer by producing a protein that stops cells from growing out of control.
在正常形式下，BRCA1和BRCA2基因通过产生阻止细胞生长失控的蛋白质来预防乳癌。
The most famous of these tests involveBRCA1 and BRCA2, two genes with variants linked to increased risk of breast and ovarian cancers.
而这其中最为著名的就是针对与BRCA1和BRCA2的检测，这两种基因的变异与升高的乳腺、卵巢癌风险相关。
This was a claim by Myriad Genetics, of Salt Lake City, to patent protection on two human genes called BRCA1 and BRCA2.
来自盐湖城的原告，基因学家Myriad，要求对两个人类基因组授予专利保护，代号为BRCA1和BRCA2。
Cancer cells with the BRCA1 or BRCA2 mutations are the first to be shown to be sensitive to PARP inhibitors.
带有BRCA1或BRCA2突变的癌细胞是第一个显示出对PARP抑制剂敏感的细胞。
Heredity accounts for about 10% of all breast cancers, and abnormal BRCA1 and BRCA2 genes explain a large number of these cancers.
这种遗传性的模式大约占所有乳腺癌患者的10%，并且BRCA1和BRCA2基因变异在这种疾病中占了很大部分。